Cargando…
The patient’s view on rare disease trial design – a qualitative study
BACKGROUND: Clinical trials in rare diseases are more challenging than trials in frequent diseases. Small numbers of eligible trial participants, often complicated by heterogeneity among rare disease patients, hamper the design and conduct of a ‘classical’ Randomized Controlled Trial. Therefore, nov...
Autores principales: | Gaasterland, C. M. W., van der Weide, M. C. Jansen –, du Prie – Olthof, M. J., Donk, M., Kaatee, M. M., Kaczmarek, R., Lavery, C., Leeson-Beevers, K., O’Neill, N., Timmis, O., van Nederveen, V., Vroom, E., van der Lee, J. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367834/ https://www.ncbi.nlm.nih.gov/pubmed/30732630 http://dx.doi.org/10.1186/s13023-019-1002-z |
Ejemplares similares
-
Development of a method to involve patients in the determination and appraisal of outcomes in clinical trials
por: Gaasterland, Charlotte M W, et al.
Publicado: (2015) -
Systematic review of Goal Attainment Scaling as an outcome measure in drug trials
por: Gaasterland, Charlotte M W, et al.
Publicado: (2015) -
Goal attainment scaling as an outcome measure in rare disease trials: a conceptual proposal for validation
por: Gaasterland, C. M. W., et al.
Publicado: (2019) -
A systematic review to investigate the measurement properties of goal attainment scaling, towards use in drug trials
por: Gaasterland, Charlotte M. W., et al.
Publicado: (2016) -
Rare disease registries: potential applications towards impact on development of new drug treatments
por: Jansen-van der Weide, Marijke C., et al.
Publicado: (2018)